Publication:
Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy

dc.contributor.authorLedesma-Corvi, Sandra
dc.contributor.authorJornet-Plaza, Jordi
dc.contributor.authorGarcía-Fuster, M Julia
dc.date.accessioned2024-10-09T06:33:33Z
dc.date.available2024-10-09T06:33:33Z
dc.date.issued2023-10-24
dc.description.abstractBackground: Ketamine has been recently approved to treat resistant depression; however preclinical studies showed sex differences in its efficacy. Sex steroids, such as estrogens and testosterone, both in the periphery and locally in the brain, are regarded as important modulators of these sex differences. Therefore, the present study evaluated how inhibiting the biosynthesis of estrogens with letrozole (an aromatase inhibitor) could affect the observed sex differences in ketamine's antidepressant-like-response. Methods: We performed several consecutive studies in adult Sprague-Dawley rats to evaluate potential sex differences in the antidepressant-like effects of ketamine (5 mg/kg, 7 days, i.p.), letrozole (1 mg/kg, 8 days, i.p.) and their combination (letrozole pre-treatment 3 h before ketamine). Acute and repeated antidepressant-like responses were ascertained in a series of behavioral tests (forced-swim, novelty-suppressed feeding, two-bottle choice for sucrose preference). Results: The main results proved clear sex differences in the antidepressant-like response induced by ketamine, which was observed following a repeated paradigm in adult male rats, but rendered inefficacious in female rats. Moreover, decreasing estrogens production with letrozole induced on itself an antidepressant-like response in female rats, while also increased ketamine's response in male rats (i.e., quicker response observed after only a single dose). Interestingly, both the antidepressant-like effects induced by ketamine in male rats or letrozole in female rats persisted over time up to 65 days post-treatment, suggesting long-term sex-directed benefits for these drugs. Conclusions: The present results demonstrated a sex-specific role for aromatase inhibition with letrozole in the antidepressant-like response induced by ketamine in male rats. Moreover, letrozole itself presented as a potential antidepressant for females with persistent effects over time. Clearly, the production of estrogens is key in modulating, in a sex-specific manner, affective-like responses and thus deserve further studies.en
dc.description.sponsorshipResearch was funded by PID2020-118582RB-I00 (MCIN/AEI/10.13039/501100011033); PDR2020/14 (Comunitat Autónoma de les Illes Balears through the Direcció General de Política Universitária i Recerca with funds from the Tourist Stay Tax Law ITS 2017-006) to MJG-F. The predoctoral program JUNIOR (IdISBa, GOIB) covered SL-C�s salary and JJ-P was funded by a predoctoral scholarship from Conselleria de Fons Europeus, Universitat i Cultura, Govern de les Illes Balears (FPI_022_2022). Open Access was funded by Programa Liberi 2023 from IdISBa.es_ES
dc.format.number1es_ES
dc.format.page73es_ES
dc.format.volume14es_ES
dc.identifier.citationLedesma-Corvi S, Jornet-Plaza J, García-Fuster MJ. Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy. Biol Sex Differ. 2023 Oct 24;14(1):73.en
dc.identifier.doi10.1186/s13293-023-00560-5
dc.identifier.e-issn2042-6410es_ES
dc.identifier.journalBiology of sex differenceses_ES
dc.identifier.otherhttps://hdl.handle.net/20.500.13003/19999
dc.identifier.pubmedID37876000es_ES
dc.identifier.puiL642600980
dc.identifier.scopus2-s2.0-85174640263
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23589
dc.identifier.wos1088134900002
dc.language.isoengen
dc.publisherBioMed Central (BMC)
dc.relation.publisherversionhttps://doi.org/10.1186/s13293-023-00560-5en
dc.rights.accessRightsopen accessen
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.decsAromatasa*
dc.subject.decsCaracteres Sexuales*
dc.subject.decsAnimales*
dc.subject.decsLetrozol*
dc.subject.decsKetamina*
dc.subject.decsAntidepresivos*
dc.subject.decsRatas*
dc.subject.decsRatas Sprague-Dawley*
dc.subject.decsDepresión*
dc.subject.decsFemenino*
dc.subject.decsEstrógenos*
dc.subject.decsMasculino*
dc.subject.meshMale*
dc.subject.meshSex Characteristics*
dc.subject.meshKetamine*
dc.subject.meshRats*
dc.subject.meshFemale*
dc.subject.meshEstrogens*
dc.subject.meshAnimals*
dc.subject.meshAntidepressive Agents*
dc.subject.meshAromatase*
dc.subject.meshDepression*
dc.subject.meshRats, Sprague-Dawley*
dc.subject.meshLetrozole*
dc.titleAromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacyen
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files